The trajectory of Viagra presents a nuanced case for investors in the drug sector. While initially a tremendous success, producing huge profits, the intellectual property end and the subsequent entry of cheaper versions have drastically changed revenue. This raises questions about the future viability of related medication developments and sugge… Read More